Clinical Trials
11 trialsNCT06897735 2026-06-03
EDDIS-a1
Petrov, Andrey
Phase 1 Terminated
NCT06673329 2026-05-13
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
Phase 1 Recruiting
NCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT03420963 2026-03-20
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00542373 2026-03-05
Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06171945 2025-10-27
AYAConnect
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
NCT06321003 2025-05-23
SYMILIS OCT
University of Palermo
Recruiting
NCT06666634 2024-10-30
NANOSCAN
The Netherlands Cancer Institute
Phase NA Recruiting
NCT05942794 2024-02-28
Identification of Oral Lesions Through an Autofluorescence System
Federico II University
Phase NA Unknown
NCT00036790 2019-12-17
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
University of Wisconsin, Madison
Phase 1 Completed
NCT00824174 2012-10-02
Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer
M.D. Anderson Cancer Center
Completed